Skip to content
Ask

Latest figures

Antiretroviral therapy coverage for PMTCT

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).

World BankSaveCreate alert
Latest, 202382%of pregnant women living with HIVAnnual release · Not updated
vs 2022+1.0 pp81%
High since 200082% of pregnant women living with HIV2023 · World Bank
Low since 20002% of pregnant women living with HIV2000 · World Bank

Over time

2013 - 2023

Recent years

  1. 202382% of pregnant women living with HIV+1.0 pp
  2. 202281% of pregnant women living with HIV+9.0 pp
  3. 202172% of pregnant women living with HIV+7.0 pp
  4. 202065% of pregnant women living with HIV+1.0 pp
  5. 201964% of pregnant women living with HIVNo change
  6. 201864% of pregnant women living with HIV+12.0 pp
  7. 201752% of pregnant women living with HIV+3.0 pp
  8. 201649% of pregnant women living with HIV+11.0 pp
Full table
PeriodValue
202382% of pregnant women living with HIV
202281% of pregnant women living with HIV
202172% of pregnant women living with HIV
202065% of pregnant women living with HIV
201964% of pregnant women living with HIV
201864% of pregnant women living with HIV
201752% of pregnant women living with HIV
201649% of pregnant women living with HIV
201538% of pregnant women living with HIV
201461% of pregnant women living with HIV
201369% of pregnant women living with HIV
201243% of pregnant women living with HIV
201159% of pregnant women living with HIV
201044% of pregnant women living with HIV
200965% of pregnant women living with HIV
200846% of pregnant women living with HIV
200751% of pregnant women living with HIV
200654% of pregnant women living with HIV
20056% of pregnant women living with HIV
20044% of pregnant women living with HIV
20033% of pregnant women living with HIV
20024% of pregnant women living with HIV
20013% of pregnant women living with HIV
20002% of pregnant women living with HIV